154 related articles for article (PubMed ID: 35687071)
1. Poorly Differentiated and Undifferentiated Pancreatic Neuroendocrine Carcinoma Management and Outcomes: A Surveillance, Epidemiology, and End Results Assessment.
Gan Y; Su S; Fang C; Li C; Wen TF
Pancreas; 2022 Apr; 51(4):e64-e65. PubMed ID: 35687071
[No Abstract] [Full Text] [Related]
2. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
[No Abstract] [Full Text] [Related]
3. The Strange Case of a Pancreatic Neuroendocrine Carcinoma With Low Proliferation Index and Atypical Clinical Behavior.
Feola T; Centello R; Sesti F; Puliani G; Verrico M; Di Vito V; Di Gioia C; Bagni O; Pisegna S; Lenzi A; Isidori AM; Giannetta E; Faggiano A
Pancreas; 2022 Feb; 51(2):e25-e27. PubMed ID: 35404907
[No Abstract] [Full Text] [Related]
4. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
Sorbye H; Baudin E; Perren A
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
[TBL] [Abstract][Full Text] [Related]
5. [Pancreatic carcinoid tumor(serotonin-producing pancreatic neuroendocrine tumor)].
Matsushita A; Nakamura Y; Uchida E
Nihon Rinsho; 2015 Mar; 73 Suppl 3():356-7. PubMed ID: 25857047
[No Abstract] [Full Text] [Related]
6. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon.
La Salvia A; Persano I; Parlagreco E; Audisio A; Cani M; Brizzi MP
Med Oncol; 2022 Aug; 39(11):168. PubMed ID: 35972607
[TBL] [Abstract][Full Text] [Related]
7. Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms.
Eads JR; Halfdanarson TR; Asmis T; Bellizzi AM; Bergsland EK; Dasari A; El-Haddad G; Frumovitz M; Meyer J; Mittra E; Myrehaug S; Nakakura E; Raj N; Soares HP; Untch B; Vijayvergia N; Chan JA
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184955
[TBL] [Abstract][Full Text] [Related]
8. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumors: contemporary diagnosis and management.
Parbhu SK; Adler DG
Hosp Pract (1995); 2016 Aug; 44(3):109-19. PubMed ID: 27404266
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
Konukiewitz B; Jesinghaus M; Kasajima A; Klöppel G
Virchows Arch; 2022 Feb; 480(2):247-257. PubMed ID: 34647171
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
12. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
13. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.
Crippa S; Partelli S; Belfiori G; Palucci M; Muffatti F; Adamenko O; Cardinali L; Doglioni C; Zamboni G; Falconi M
World J Gastroenterol; 2016 Dec; 22(45):9944-9953. PubMed ID: 28018101
[TBL] [Abstract][Full Text] [Related]
14. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
15. TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas--a single-institution experience.
Sellner F; Thalhammer S; Stättner S; Karner J; Klimpfinger M
J Surg Oncol; 2011 Jul; 104(1):17-21. PubMed ID: 21360536
[TBL] [Abstract][Full Text] [Related]
16. Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region.
Nakakura EK; Bergsland EK
Hematol Oncol Clin North Am; 2007 Jun; 21(3):457-73; viii. PubMed ID: 17548034
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma.
Takahashi K; Ozawa E; Nakao K; Aoki S; Takase Y
J Gastroenterol Hepatol; 2019 Jun; 34(6):964. PubMed ID: 30663800
[No Abstract] [Full Text] [Related]
18. [Trends of epidemiology of pancreatic endocrine tumors: a nationwide survey analysis in Japan].
Ito T; Igarashi H; Nakamura K; Okusaka T; Imamura M
Nihon Rinsho; 2015 Mar; 73 Suppl 3():316-20. PubMed ID: 25857040
[No Abstract] [Full Text] [Related]
19. Malignant Insulinoma Is Largely Derived From Nonfunctioning Pancreatic Neuroendocrine Tumors: A Contemporary View.
Yu R
Pancreas; 2020 Jul; 49(6):733-736. PubMed ID: 32590616
[No Abstract] [Full Text] [Related]
20. Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
Thomas KEH; Voros BA; Boudreaux JP; Thiagarajan R; Woltering EA; Ramirez RA
Oncologist; 2019 Aug; 24(8):1076-1088. PubMed ID: 30635447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
